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(∼108 TCID50/ml) but not in Vero cells (105—6 TCID50/ml)
which is the most common cell line for manufacturing
human vaccines. After several passages and plaque puriﬁca-
tions, two Vero-adapted high growth inﬂuenza H5N1 vaccine
viruses (Vero-15 and Vero-16) have been selected and could
reach high virus titer (108 TCID50/ml) in Vero cells in T
ﬂasks. After tested with NIBRG-14 standard antiserum pro-
vided by the NIBSC, antigenicity of the Vero-15 and Vero-16
viruses remain similar to the NIBRG-14 virus. In addition,
the Vero-15 and Vero-16 viruses do not have any nucleotide
difference in HA and NA gene segments compared with the
NIBRG-14. For process development, Vero cells were fur-
ture cultured on cytodex 1 microcarriers in spinner ﬂasks.
Vero cells growed to 3× 106 cells/ml with a seeding density
of 4.4× 105 cells/ml in 5 g/L microcarriers and peak virus
titers reached 109 TCID50/ml. In conclusion, the Vero-15 and
Vero-16 viruses are suitable for production of inﬂuenza H5N1
vaccines in Vero cells. Their other six internal gene segments
could also be used to generate vaccine seed viruses of other
inﬂuenza subtypes for production in Vero cells.
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Streptococcus pneumoniae (pneumococcus) is an impor-
tant pathogen that causes pneumonia, meningitis and otitis
media. Invasive diseases usually follow colonization of the
respiratory tract and may be favored by factors that cause
immunosupression. Several pneumococcal proteins actively
participate of these events playing different roles such as
facilitating bacterial adhesion to epithelial cells or evasion
from the immune system. Pneumococcal Surface protein
C (PspC) is a virulence factor that has been implicated
both in colonization and in invasive phases of pneumococcal
diseases. Antigen delivery systems based on live recombi-
nant lactic acid bacteria represents a promising strategy
for mucosal vaccination, since they are able to elicit both
systemic and mucosal immune responses. In the present
work, we have evaluated the immune response and the
protective activity of nasal vaccines composed of recom-
binant PspC (rPspC) or Lactobacillus casei expressing PspC
(L.c.PspC). Nasal immunization of mice with both formula-
tions did not elicit the production of anti-PspC IgG or IgA.
On the other hand, ELISPOT and cytokine ELISA analysis of
cultures obtained from mice 13 h after intranasal challenge
with a virulent pneumococcal strain, showed an increase
in IFN- secretion in lung cells from mice immunized with
L.c.PspC and to a lesser extent, rPspC. This cytokine was also
produced by spleen cells from mice immunized with both
formulations. Production of IL-17 by lung cells was observed
in the group immunized with rPspC whereas immuniza-
tion with L.c.PspC induced the production of this cytokine
only by spleen cells. IL-17 has already been implicated in
the protection against colonization conferred by a cellular
pneumococcal vaccine. Nevertheless, the induction of this
cytokine or IFN- by our vaccines did not confer protection
against an invasive challenge with pneumococci. Further
studies will be necessary for the evaluation of protection
against nasal colonization.
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Since 1997, large epidemics of EV71 infection have been
reported in East and Southeast Asia. The virus has caused
numbers of outbreak and infection associated with fatal neu-
rological complications, however no vaccine nor antiviral
against EV71 are available. In our study, we have devel-
oped DNA-based vaccines against EV71. The vaccines consist
of structural protein VP1 of human enterovirus 71 (EV71)
as fusion proteins with enhanced green ﬂuorescent protein
(EGFP), with and without the presence of internal ribosome
entry site (IRES) at the 5′-end; IRESVP1/EGFP and VP1/EGFP.
Expressions of both constructs were evaluated in vitro using
Vero and SK-N-MC cells, and later in vivo in murine model.
Evaluation of in vitro expression showed that the VP1 gene
expressed by 5′UTR-VP1/EGFP is higher in comparison to
construct without IRES; VP1/EGFP, in both Vero and SK-N-MC
cells. The ability of the constructed DNA vaccines in elicit-
ing immune responses were evaluated in vivo using murine
model. Themice were immunized with 2 dosages of DNA vac-
cine followed by experimental challenge. In vivo evaluation
showed that the mice group immunized with IRESVP1/EGFP
confer a higher neutralizing antibody titer in comparison to
the VP1/EGFP. Results from our study not only demonstrate
the potential of VP1-based DNA vaccine but also suggests the
feasibility of using IRES to generate better protective immu-
nity in mice against EV71 and the possibility to develop safe
vaccine against enterovirus infection.
doi:10.1016/j.ijid.2008.05.689
43.010
Protective Immunity Induced by Baculovirus-Expressed
Rabies Glycoprotein and Recombinant Adenovirus
Expressing Its Protein
K.K. Lee ∗, B.J. So, C.K. Park, J.K. Oem, S.H. Kim, H.R. Kim,
C.H. Kwon, Y.S. Joo
National Veterinary Research and Quarantine Service,
Anyang, Republic of Korea
Background: Since rabies virus (RV) infection is fatal
for both human and animals, the protective immunization
by vaccines is of critical importance for disease con-
trol and prevention. Several recombinant protein and live
viruses of rabies have been constructed and tested for their
